MEDVi vs Gala GLP-1 vs PlexusDx (2026): Verified Pricing & Best Fit | PlexusDx

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you're cross-shopping MEDVi and Gala GLP-1 for cash-pay weight loss, the headlines do a lot of work. MEDVi advertises a $179 first month then ~$299/month refills. Gala advertises $179/month on a 12-month prepay or $199/month on a 3-month plan. The real question is what compound you're getting, how long you're locked in, and whether anyone has stratified your dose to your biology. This article walks the cost math, the compounded picture, and where PlexusDx Semaglutide Injection, Tirzepatide Injection, and the Microdose GLP-1 Protocol sit relative to both.

MEDVi vs Gala GLP-1 vs PlexusDx — quick decision frame

Three cash-pay compounded GLP-1 platforms, three pricing structures. MEDVi uses a low-first-month, higher-refill model: $179 to start, then ~$299/month all-inclusive. Gala GLP-1 ties price to commitment: $179/month on 12-month prepay ($2,148 up front), $199/month on a 3-month plan, or $149/month microdose on annual prepay. PlexusDx Weight Management Protocols are month-to-month with no membership fee and no prepay: Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $149/mo, Tirzepatide Injection at $249/mo, Semaglutide Oral from $249/mo, Tirzepatide Oral at $279/mo, and GLP-Squared at $249/mo. Add the optional Precision Peptide Genetic Test ($298 standalone, or $99 as an add-on after month one) so dosing is anchored to GIPR rs1800437, GLP1R, FTO, MC4R, and TCF7L2 rather than population averages. All three are cash-pay; none bill insurance.

The real annual cost: MEDVi vs Gala vs PlexusDx

MEDVi lands at roughly $3,468/year on standard injection ($179 + $299 × 11). Gala is $2,148/year on annual prepay, $1,788/year on the $149 microdose annual tier, or $2,388/year on the 3-month plan. PlexusDx ranges from $1,548/year on Microdose GLP-1 Protocol to $2,148–$2,748/year on Semaglutide Injection and $2,748–$3,708/year on Tirzepatide Injection. Add $99 for the Precision Peptide Genetic Test after month one and the genetic-baseline-included totals stay below MEDVi at entry tiers and competitive with Gala without a year of cash up front. The structural difference is timing: Gala's lowest sticker requires a $2,148 check today and a 12-month commitment; PlexusDx is month-to-month, so you can change protocols as your response data warrants.

Compounded vs FDA-approved — what each platform dispenses

All three primarily dispense compounded semaglutide and tirzepatide — prepared by licensed U.S. compounding pharmacies under Section 503A. Compounded GLP-1 is not an FDA-approved finished product at any of these providers; it uses the same active ingredients as Wegovy, Ozempic, Mounjaro, and Zepbound. Delivery format diverges. MEDVi offers compounded injection plus dissolvable tablets and a separate $99 membership path to FDA-approved Wegovy and Zepbound. Gala focuses on compounded injection in standard and microdose tiers and adds HRT for menopause. PlexusDx offers four delivery formats across six protocols — injection, oral tablet, microdose, and the GLP-Squared dual-compound stack — so a patient with needle aversion or who wants the lowest entry price has a path without switching providers.

Safety, side effects, and clinical oversight

All three prescribe medications in the GLP-1 receptor agonist class (and tirzepatide, a GIP/GLP-1 dual-agonist). Nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common; pancreatitis, gallbladder disease, and acute kidney injury are documented but less common. The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies — a contraindication for personal or family history of medullary thyroid carcinoma or MEN 2. The differentiator across platforms is titration. MEDVi and Gala start from a population-average schedule and adjust on subjective tolerability across the first 8–12 weeks. PlexusDx's clinical team can review the patient's Precision Peptide Genetic Test before titration when the test is included — a step neither MEDVi nor Gala performs.

Why genetics matter before you choose

GLP-1 response varies meaningfully across patients. Variants in GLP1R, GIPR (rs1800437 is the headline variant for differential GLP-1 response), FTO, MC4R, and TCF7L2 are associated with measurably different response patterns. The Precision Peptide Genetic Test maps 48 genes and 57 variants across 14 health pathways — including 34 weight-management insights — so the clinician knows whether a faster titration, a slower one, or a tirzepatide-first approach fits your biology before week one. At $298 standalone or $99 after month one, it's the cheapest way in this comparison to put a measurable variable into a decision that otherwise leans on subjective tolerability for months.

Cancellation, refunds, and who fits where

MEDVi and Gala both require cancellation at least 72 hours before the next billing date and auto-renew unless canceled. MEDVi refunds the remainder if a patient is medically disqualified; Gala's terms are similar but limit refund eligibility on shipped medication. PlexusDx is month-to-month with no annual lock-in. Quick frame: if you'll prepay 12 months, Gala's $2,148 is the lowest sticker. If you want the cheapest first month, MEDVi's $179 wins. If you want non-injection formats, PlexusDx has all four. If you want a genetic baseline informing dose, PlexusDx is the only option offering the Precision Peptide Genetic Test on the protocol pathway. Five U.S. states require a live consultation; eligibility is confirmed before payment.

Frequently asked questions

Is Gala GLP-1 cheaper than MEDVi?

On long-term tirzepatide, Gala's $179/month annual prepay ($2,148 up front) beats MEDVi's ~$299/month refill rate. MEDVi's $179 first month is the cheapest single-month entry. PlexusDx Microdose GLP-1 Protocol at $129/mo flat is below both on month-to-month with no prepay.

Are MEDVi and Gala GLP-1 the same company?

No. MEDVi, LLC is in Newark, Delaware; Gala GLP-1 is operated by AI Coaching, Inc. in Wilmington, Delaware. Separate legal entities, different founders and billing systems, though both reference clinicians from OpenLoop Health's network and have overlapping pharmacy partners.

Is MEDVi legit after the FDA warning letter?

The February 20, 2026 FDA Warning Letter to MEDVi cited misbranded marketing language — specifically website language implying FDA approval of compounded products. It required corrective action; it did not cite a recall, patient injury, or manufacturing failure. Compounded GLP-1 is not FDA-approved at any provider, including PlexusDx.

Which has better tirzepatide pricing — MEDVi, Gala, or PlexusDx?

Gala's annual prepay is $179/month ($2,148/year). PlexusDx Tirzepatide Injection runs $249/mo month-to-month with no annual lock-in. MEDVi refill pricing has been reported around $299/month after the $179 first month. Trade-off: sticker vs flexibility.

Can you cancel MEDVi or Gala GLP-1 easily?

Both require cancellation at least 72 hours before the next billing date and auto-renew unless canceled. Most public complaints trace to patients who missed the window or asked for a partial refund on annual prepay. PlexusDx is month-to-month with no prepay, so the cancellation surface is smaller by design.

Does insurance cover MEDVi, Gala, or PlexusDx?

None of the three bill insurance for compounded GLP-1. All are cash-pay. HSA/FSA cards may be accepted at intake — verify before paying. For insurance-covered FDA-approved Wegovy or Zepbound, you would need a platform that routes branded prescriptions through retail pharmacies.

Are compounded GLP-1 medications FDA-approved?

No. Compounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by licensed compounding pharmacies under Section 503A. The FDA does not review compounded medications for safety, effectiveness, or quality before marketing. This applies to MEDVi, Gala, and PlexusDx alike.

Related reading on PlexusDx

Related reading on PlexusDx: GLP-1 Cost, Cheapest GLP-1, Tirzepatide Costs, Semaglutide Cost.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for MEDVi and Gala GLP-1 is based on each provider's published rates as of April 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.